RLAY
Relay Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.19 / 10
Netural
Fund-flow score of 7.61/10 indicates robust money inflows, especially at Small, Medium, and Large sizes, despite negative trends in Extra-large blocks. Analyst coverage is thin—only Oppenheimer is active—but their rating is Buy, aligning with the positive fund-flow picture. Together, the data point to a cautiously bullish sentiment.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-26
InstitutionOppenheimer
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for RLAY?
- RLAY holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.19/10 (Netural).
